Terumo holds above its 200-day line, shares steady on Tokyo exchange

By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 15:54.

Terumo (JP3443600006) remains a closely followed medtech name on the Tokyo Stock Exchange, where its shares trade slightly above a key 200-day moving average as of late June 2026. The Japanese group continues to draw attention from investors focusing on defensive healthcare stocks and technical support zones, with its chart picture used as a reference in the wider medical device sector.

How Terumo trades in Tokyo

Terumo shares trade on the Tokyo Stock Exchange under the ticker 4543, giving the company a direct link into the Japanese benchmark indices that many international investors monitor for exposure to the local healthcare market. Its listing in Japan places the stock alongside peers such as Olympus and Nipro, which also focus on medical devices and consumables in the domestic and global hospital market.

The company is part of the TOPIX index on the Tokyo Stock Exchange, making it a constituent in many passive strategies that track broad Japanese equities. That membership helps sustain liquidity in Terumo shares, with institutional investors often using the TOPIX basket and related exchange-traded funds to gain or adjust exposure to Japan's healthcare and medtech segment. In this context, Terumo's trading profile benefits from the structural demand for index-linked investments that include the stock.

Technical picture and 200-day line

From a chart perspective, Terumo shares currently trade slightly above their 200-day moving average, a level many technical analysts watch as a medium-term trend indicator in developed equity markets. When a stock holds above this moving average, it is often described as being in a constructive or upward-biased trend, even if short-term fluctuations around the line occur regularly within daily trading.

Japanese medtech names such as Terumo, Olympus and Nipro frequently show relatively stable chart formations compared with more cyclical sectors, given the defensive nature of the underlying healthcare demand. The 200-day line in Terumo's case functions as an approximate support zone, where buyers often step in if the shares drift closer to that technical level, while longer term holders use the line to gauge whether the stock remains aligned with their risk tolerance and investment horizon.

What the company sells

Terumo generates its revenue primarily through medical devices for hospitals and clinics, with a strong focus on blood management, cardiovascular systems and general medical products. The company sells items such as blood collection systems, catheters, stents and infusion sets that are used in routine and advanced procedures in healthcare facilities worldwide.

Where the stock trades today

Terumo shares last traded at approximately 2,550 Japanese yen on the Tokyo Stock Exchange, with the price as of 2026-06-25, 15:30 JST providing the reference point for investors tracking the stock in real time.

This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.